【C.S】Cordyceps Sunshine Group Enters Strategic Partnership with Yue Hwa Chinese Products Emporium

TAIPEI, Oct. 8, 2024 /PRNewswire/ -- Cordyceps Sunshineã€C.S】Group, Taiwan's largest chain specializing in the medicinal mushroom, Antrodia cinnamomea, has officially signed a strategic partnership agreement with Hong Kong's renowned department store group, Yue Hwa Chinese Products Emporium Limited, on July 9, 2024. Under this agreement, Yue Hwa will exclusively distributeã€C.S】Group's Antrodia cinnamomea health products, branded as "KASAER," across its extensive retail network in Hong Kong.

This collaboration signifies Yue Hwa's strong recognition ofã€C.S】Group's innovative cultivation techniques and brand philosophy. By partnering with Hong Kong's largest department store group,ã€C.S】Group aims to expand its presence in the Greater China market for traditional Chinese medicine and health supplements.

ã€Background and Industry Standing of Yue Hwa Chinese Products Emporium】

Yue Hwa Chinese Products Emporium, established in Hong Kong in 1959, is a major retail group specializing in Chinese goods. Known for its rich history and reputable standing, "Yue Hwa" symbolizes the prosperity of Chinese culture. In 1976, Yue Hwa became the first department store in Asia to implement computerized cash registers, showcasing the visionary foresight of its management.

From its humble beginnings as a small store, Yue Hwa has grown into a significant retail conglomerate, operating department stores, specialty Chinese medicine shops, and health product chains. The company offers a wide range of unique products from Greater China, including rare treasures, apparel, furniture, and herbal medicines, with operations in Hong Kong and Singapore.

Yue Hwa is committed to promoting Chinese goods, adhering to principles of comprehensive stock, authenticity, superior quality, and excellent service. Their strategic business approach, "Keeping pace with the times, staying in sync with society, and aligning with customers," has allowed them to maintain a leading position in Hong Kong's retail sector. In response to changing consumer habits, Yue Hwa began developing its online shopping platform in 2011, enhancing the shopping experience with Facebook and WeChat integration to attract younger customers.

The company's senior management has noted in media interviews that their Chinese medicine department's revenue has shown stable growth, regardless of economic fluctuations. This trend is attributed to the increasing health consciousness among Chinese communities and the global trend towards natural herbal remedies.

ã€C.S】Group 's Leadership in the Medicinal Mushroom Market

This strategic partnership with Yue Hwa Chinese Products Emporium will further strengthenã€C.S】Group's market position and brand recognition in the Greater China region. By leveraging Yue Hwa's extensive retail network,ã€C.S】Group aims to accelerate its industry presence and prepare for expansion into other Asian markets, promising a bright future for their innovative health products.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

【C.S】Cordyceps Sunshine Group Enters Strategic Partnership with Yue Hwa Chinese Products Emporium

Launched to mark the company's 10th anniversary, Osara Health's Global Cancer Support Declaration has already secured signatures from healthcare professionals worldwide.

NEW YORK, Aug. 12, 2026 /PRNewswire/ -- Osara Health, a global digital health company focused on the human experience of cancer care, marks 10 years since its founding with 527 healthcare professionals signing its Global Cancer Support Declaration.

Launched earlier this year, the declaration calls for people living with and beyond cancer to receive support that extends beyond treatment. Signatories include oncologists and cancer specialists worldwide, with a goal of 2,000 signatures by year-end.

Founded in 2016, Osara Health delivers cancer support programs through leading insurers and employers across the United States, Canada, Australia, and New Zealand.

The milestone comes as cancer's impact on working-age populations grows. 45% of cancer diagnoses occur during working life, while improving survival means more people are living with and beyond cancer.

Today, Osara Health supports more than 11 million covered lives through partnerships with organizations including MetLife, Manulife, Guardian, Allstate Benefits, nib, GMHBA, and UniMed. Its programs are backed by more than 11 peer-reviewed studies, including recent findings published in JMIR Cancer in 2026 showing significant improvements in physical and mental health outcomes.

"As an oncologist, I watched people receive excellent treatment and then return home to manage fear, fatigue, work, and family largely on their own. Osara Health was founded to address the human side of cancer: how people feel, function, and live after diagnosis. Seeing colleagues around the world put their names to that belief is the best anniversary gift we could ask for," said Dr Raghav Murali-Ganesh, CEO, Co-Founder of Osara Health, and Radiation Oncologist.

"We started with an app, but the lesson of our first decade is simple: people do better when someone is in their corner between appointments," said Tim Atkins, Co-Founder and COO of Osara Health. "The declaration is an invitation to make that support standard, wherever someone is diagnosed."

To mark the anniversary, Osara Health has released 10 Years Supporting the Human Side of Cancer, available at https://osarahealth.com/2026-declaration.

About Osara Health
Osara Health is a global digital health company transforming the human side of cancer care through evidence-based behavior change science, human coaching, and digital tools. Learn more at osarahealth.com.

Media Contact
Paul Oganyan, Senior Marketing Manager
marketing@osarahealth.com

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Osara Health Marks 10 Years with Global Call to Make Cancer Support Beyond Treatment Standard